Indeed, pre-existing influenza-specific CD4+ T cells were shown to protect against symptomatic illness in both H3N2 and H1N1 human challenge models69 and CD8+ T cell responses were correlated with better clinical outcomes during the 2009 H1N1 pandemic in United Kingdom.70 The gene discussed is CD4; the disease is influenza.